IDXX vs TERN · P/E 40, rev $2.36B vs $6.12B cap
IDEXX Laboratories Inc (IDXX) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. TERN currently screens at market cap $6.12B.
Not investment advice. Open the IDXX and TERN stock pages for the full models.
Not investment advice.